Stay updated on Intermittent Therapy in RCC Patients: Clinical Trial
Sign up to get notified when there's something new on the Intermittent Therapy in RCC Patients: Clinical Trial page.

Latest updates to the Intermittent Therapy in RCC Patients: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoChange DetectedThe webpage has undergone significant updates, including the addition of the study title 'A Single-arm Phase II Trial of Intermittent Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy' and the mention of 'Metastatic Renal Cell Carcinoma' as a key focus. Additionally, the revision number has been updated to v2.15.0.SummaryDifference38%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Intermittent Therapy in RCC Patients: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intermittent Therapy in RCC Patients: Clinical Trial page.